期刊文献+

药物-心理-社会综合干预模式对精神分裂症患者结局的疗效 被引量:6

The effect of drug-psychological-social comprehensive intervention model for the overall outcome of schizophrenic patients
原文传递
导出
摘要 目的验证药物-心理-社会综合干预模式对精神分裂症结局的疗效。方法将济宁市精神病防治医院2010年1月至2012年6月收治的200例符合美国精神病学会制定的《诊断与统计手册:精神障碍(第4版)》(DSM-Ⅳ)和《中国精神障碍分类与诊断标准(第3版)》(CCMD-3)诊断标准的精神分裂症患者随机分为两组,一组实施药物-心理-社会综合干预模式(综合组),另一组实施常规抗精神病药物治疗,不进行心理-社会干预。干预3个月并随访1年,对两组的阳性与阴性症状量表(PANSS)、大体评定量表(GAS)、社会功能缺陷筛选量表(SDSS)及健康状况问卷(SF-36)评分情况进行比较。所有数据采用统计学软件SPSS 16.0进行统计学处理。结果 (1)随访1年后,综合组的总治疗中断率为14%(14例),对照组为32%(32例)(χ2=9.147,P<0.01);复发率综合组为12%(12例),对照组为24%(24例)(χ2=4.878,P<0.01);治疗依从性差或违背治疗方案率综合组为6%(6例),对照组为13%(13例)(χ2=3.843,P<0.05);再入院率综合组为6%(6例),对照组为13%(13例)(χ2=3.843,P<0.05);自杀率(包括自杀行为、自杀未遂和自杀死亡)综合组为5%(5例),对照组为12%(12例)(χ2=3.846,P<0.05);再就业或入学率综合组为32%(32例),对照组为18%(18例)(χ2=5.227,P<0.01)。(2)随访1年综合组PANSS、GAS、SDSS评分变化与对照组比较差异有统计学意义(t=5.634,P<0.01,t=7.268,P<0.01,t=3.8365,P<0.05)。(3)随访1年综合组和对照组SF-36总分及各因子分比较差异均有统计学意义(P<0.05或P<0.01)。结论药物-心理-社会综合干预模式能显著改善精神分裂症的总体结局和生活质量,值得临床推广使用。 Objective Ta verify the effect of drug-psychological-social comprehensive intervention model for the overall outcome of schizophrenic patients. Methods Two hundred schizophrenic patients who met with diagnostic and statistical manual of mental disorders ( DSM-IV ) and chinese classfication and diagnostic criteria of disorders Ⅲ( CCMD-Ⅲ ) criteria were divided randomly into comprehensive group( n = 100) and control group ( n = 100). Comprehensive group received drug-psychological-social comprehensive intervention for three monthes, control group received routine drug treatment. Two groups were followed up for one year, the scores of positive and negative syndrome scale ( PANSS), global assessment scale ( GAS), social disability screening schedule (SDSS) and the MOS item short from health survey (SF-36) in the two groups were compared. All data were processed by SPSS 16.0 statistically. Results (1)There were significant differences in the following indexes between two groups such as discontinuation rate( 14% vs 32%, X2 =9. 147, P 〈0.01 ), relatpse rate( 12% vs 24%, X2 =4. 878, P 〈0.01 ), poor compliance rate(6% vs 13% ,X2 = 3. 843, P 〈 0.05 ) , hospital readmission ( 6% vs 13%, X2 = 3. 843, P 〈 0.05 ) ; suicide rate (include suicide behavior, suicidal attempt and complete suicide, 5% vs 12%, g2 = 3. 846, P 〈 0.05 ) ; reemployment or return to school ( 32% vs 18% , X2 = 5. 227, P 〈 0. O1 ). ( 2 ) There were significant differences in the changes of the the following three scales of PANSS, GAS and SDSS between two groups( t = 5. 634, P 〈 O. 01, t = 7. 268, P 〈 0. 01, t = 3. 836, P 〈 0. 05 ). (3) There were significant differences in the total scores and factor scores of SF-36 between two groups ( P 〈 0.05 or P 〈 0.01 ). Conclusion Drug- psychological-social comprehensive intervention model was effective for the overall outcome and the quality of life of schizophrenic patients, thus worth being popularized in clinical psychiatry.
出处 《中华脑科疾病与康复杂志(电子版)》 2012年第1期53-57,共5页 Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition)
基金 济宁市医药卫生科技项目(2011-37)
关键词 精神分裂症 结局 心理-社会干预 抗精神病药 Schizophrenia Outcome Psychological-social intervention Antipsychotic agents
  • 相关文献

参考文献15

  • 1Jones C,Hacker D,Cormac I. Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia[J].Cochrane Database of Systematic Reviews,2012,(04):CDOO8712.
  • 2Phanthunane P,Whiteford H,Vos T. Economic burden of schizophrenia:empirical analyses from a survey in Thailand[J].JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS,2012,(01):25-32.
  • 3Péntek M,Harangozó J,Egerházi A. Health related quality of life and disease burden of patients with schizophrenia in Hungary[J].Psychiatr Hung,2012,(01):4-17.
  • 4Ojeda N,Pena J,Bengoetxea E. Evidence of the effectiveness of cognitive rehabilitation in psychosis and schizophrenia with the REHACOP programme[J].Revue Neurologique,2012,(10):577-586.
  • 5Hegde S,Rao SL,Raguram A. Addition of home-based cognitive retraining to treatment as usual in first episode schizophrenia patients:a randomized controlled study[J].Indian J Psychiatry,2012,(01):15-22.
  • 6赵靖平.精神分裂症综合康复技术使用手册[M]上海:上海人民出版社,20103-123.
  • 7American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders[M].Washington,DC:American Psychiatric Association,1994.112-119.
  • 8中华医学会精神科分会.中国精神障碍分类与诊断标准[M]济南:山东科学技术出版社,200175-78.
  • 9张作记.行为医学量表手册[M]北京:中华医学电子音像出版社,200554-156.
  • 10Lehman AF,Lieberman JA,Dixon LB. Practice guideline for the treatment of patients with schizophrenia,second edition[J].American Journal of Psychiatry,2004,(2 Suppl):1-56.

同被引文献56

引证文献6

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部